Eli Lilly is picking up its second…
Eli Lilly is picking up its second in vivo CAR-T [...]
Eli Lilly is picking up its second in vivo CAR-T [...]
Following its move to secure ex-China rights to the CD38-directed [...]
Genentech has launched the “Life Doesn’t Wait” campaign to mark [...]
Neurogene is looking to make the leap from a clinical [...]
Biovac has secured a $108.3 million financing package that will [...]
Novo Nordisk is gearing up to submit its rare blood [...]
Theramex has opted out of the U.K.’s self-regulatory program for [...]
In a blow to Bayer, a U.S. federal judge in [...]
Asked by Fierce if he’d consider returning to the FDA, [...]
A chemist, she lent her expertise in drug research to [...]